Utility of the tumor bed marker in patients with breast cancer receiving induction chemotherapy.
OBJECTIVE
Induction or neoadjuvant chemotherapy is used in patients with locally advanced breast cancer to offer a higher rate of conservative surgery. The possibility of reduction in size, even in some cases complete clinical and mammographic regression, can make the localization of the tumor bed difficult at the time of surgery. The purpose of this study was to describe our experience about the utility of US-guided implantation of a metallic marker in patients with breast cancer before induction chemotherapy.


METHODS
Forty-three patients with 44 masses were diagnosed with percutaneous biopsy of breast carcinoma. Before beginning of the induction chemotherapy all of them were referred for metallic marker placement. A metallic harpoon was placed under US guidance.


RESULTS
One patient died during the chemotherapy. Six underwent mastectomy, and 9 still had a palpable tumor at the time of surgery. In the remaining 27 patients (with 28 lesions) pre-operative wire localization of the tumor bed was carried out: in 11 cases the harpoon was necessary for the localization of the tumor bed, in 6 the harpoon was useful, and in 11 patients the localization of the tumor could have been done without the marker. No complications were observed and the marker remained stable in all patients.


CONCLUSIONS
In patients who undergo induction chemotherapy, the placement of a metallic harpoon under US guidance is a safe, simple and inexpensive technique for localization of the tumor bed previous to conservative surgery.
Alonso-Bartolome
P
P
Division of Radiology, University Hospital Marqués de Vadecilla, Faculty of Medicine, Cantabria University, Avenida Valdecilla s/n, ES-39008 Santander, Spain.
Ortega Garcia
E
E
Garijo Ayensa
F
F
de Juan Ferre
A
A
Vega Bolivar
A
A
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D014408:Biomarkers, Tumor; D001943:Breast Neoplasms / Q000000981:diagnostic imaging* / Q000188:drug therapy* / Q000601:surgery; D002277:Carcinoma / Q000000981:diagnostic imaging* / Q000188:drug therapy* / Q000601:surgery; D005260:Female; D006801:Humans; D008670:Metals; D008875:Middle Aged; D020360:Neoadjuvant Therapy; D011446:Prospective Studies; D014463:Ultrasonography
D014408:Biomarkers, Tumor; D008670:Metals